Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial

Last updated: April 28, 2025
Sponsor: Carsten Dirksen
Overall Status: Active - Recruiting

Phase

N/A

Condition

Weight Loss

Diabetes Prevention

Obesity

Treatment

Intensive weight loss intervention

Bariatric surgery

Clinical Study ID

NCT06309238
LightBAR
  • Ages 18-60
  • All Genders

Study Summary

With this trial, the aim is to assess the benefits and harms of a non-surgical intensive weight loss intervention that includes total dietary replacements, behavioural support and weight-loss medication compared with bariatric surgery for people with severe and complex obesity. The interpretation of the results will help inform future care pathways for people with obesity in whom bariatric surgery is currently the only available effective treatment option.

Eligibility Criteria

Inclusion

Please note that participants need to be invited in order to take part in the trial.

Inclusion Criteria:

  • Aged 18 to 60 years (inclusive) at time of screening.

  • Eligible for and willing to undergo bariatric surgery, i.e., fulfilment of criteriafor bariatric surgery from the respective national health authorities:

  • DK: BMI ≥ 35 kg/m2 with one or more of the following: T2D, severe hypertension,sleep apnoea requiring treatment, symptomatic arthrosis in lower extremities,female infertility related to overweight, or BMI>40 kg/m2 with other strongmedical reasons for weight loss (28). Prior to surgery, an 8% weight loss isrequired as well as smoking cessation.

  • UK: BMI of 35 kg/m2 to 40 kg/m2 and other significant disease (e.g., type 2diabetes or high blood pressure), or BMI ≥40 kg/m2. Has been or is willing toreceive intensive management in a specialist tier 3 obesity service (29).

  • Fit for anaesthesia and surgery.

  • Informed consent.

Exclusion

Exclusion Criteria:

  • Prior bariatric or hiatal surgery, not including intragastric balloons orduodenal-jejunal bypass sleeve (Endobarrier™ or similar) if the device has beenremoved >1 year before screening.

  • Use of any WLM (including liraglutide and semaglutide for diabetes) within last 3months.

  • Conditions that contraindicate or complicate total diet replacement (including type 1 diabetes or other diabetes requiring basal bolus insulin therapy or insulin pumptherapy (for Denmark) and any diabetes requiring insulin therapy (for UK),phenylketonuria, or other conditions requiring strict adherence to special diets).

  • Conditions that contraindicate or complicate treatment with GLP-1 receptor analogues (including history of pancreatitis or known allergies).

  • Conditions that contraindicate or complicate bariatric surgery (GI motilitydisorders, large abdominal wall hernia, large hiatus hernia (>5cm), Crohn's disease,liver cirrhosis, or other conditions preventing laparoscopic bariatric surgery e.g.multiple previous abdominal surgery).

  • Conditions that contraindicate or complicate study adherence and bariatric surgery (mental disorder, unstable psychiatric disease, recent history of alcohol/medicationabuse, cancer treatment within 5 years).

  • Pregnant or planning pregnancy in the next two years or currently breast feeding.

  • Not achieving a 5% weight loss within 12 weeks prior to randomisation.

  • People taking part in other research involving multidisciplinary obesity treatmentthat would compromise their participation in this trial.

  • Another member of the household enrolled in the trial.

  • Diagnosis of or treatment for severe eating disorder within the last 6 months.

Study Design

Total Participants: 500
Treatment Group(s): 2
Primary Treatment: Intensive weight loss intervention
Phase:
Study Start date:
May 08, 2024
Estimated Completion Date:
December 31, 2048

Study Description

In the LightBAR trial, an intensive weight loss (IWL) intervention will be compared with bariatric surgery. The IWL consists of three phases:

'Induction' phase (week 0-12 after randomisation): total dietary replacement (TDR) programme and behavioural support with weight loss medication (WLM) if rate of weight loss is insufficient.

'Weight loss continuation' phase (week 13-32 after randomisation): progression of dietary programme including reduction in use of TDR products, reintroduction of healthy foods, with behavioural support, introduction of physical activity, WLM (as required).

'Maintenance' phase (week 33-104 after randomisation): Continued healthy diet and physical activity with WLM (if required), with return to induction phase if weight regain occurs induction, weight loss continuation, maintenance. The IWL lasts two years, and includes total dietary replacements, behavioural support, and weight loss medication. Bariatric surgery will be standard Roux-en-Y gastric bypass or sleeve gastrectomy.

Connect with a study center

  • Steno Diabetes Center Aarhus, Aarhus Universitets Hospital

    Aarhus, 8200
    Denmark

    Active - Recruiting

  • The Department of Medicine and Department of Surgery, University Hospital of South West Jutland

    Esbjerg, 6700
    Denmark

    Active - Recruiting

  • The Department of Medicine and the Gastro Unit, Copenhagen University Hospital - Amager and Hvidovre

    Hvidovre, 2650
    Denmark

    Active - Recruiting

  • The Department of Medicine and the Department of Surgery, Zealand University Hospital Køge

    Køge, 4600
    Denmark

    Site Not Available

  • Department of Surgery, Viborg Regional Hospital

    Viborg, 8800
    Denmark

    Active - Recruiting

  • The Royal Cornwall Hospital

    Truro, Cornwall TR1 3LJ
    United Kingdom

    Active - Recruiting

  • Queen Alexandra Hospital

    Cosham, Portsmouth PO6 3LY
    United Kingdom

    Active - Recruiting

  • St Richard's Hospital

    Chichester, Sussex PO19 6SE
    United Kingdom

    Active - Recruiting

  • Southmead Hospital, North Bristol NHS Trust

    Bristol, BS10 5NB
    United Kingdom

    Active - Recruiting

  • Southampton General Hospital, University Hospital Southampton NHS Foundation Trust

    Southampton, SO16 6YD
    United Kingdom

    Site Not Available

  • Musgrove Park Hospital, Somerset Foundation NHS Trust

    Taunton, TA1 5DA
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.